Hypertrophic cardiomyopathy

Anesthesiology

Volumn 104, Issue 1, 2006, Pages 183-192

  Poliac, Liviu C ^a   Barron, Michael E ^a   Maron, Barry J ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIARRHYTHMIC AGENT; ANXIOLYTIC AGENT; ATROPINE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DESFLURANE; DISOPYRAMIDE; DOBUTAMINE; DOPAMINE; EPHEDRINE; ESMOLOL; GLYCERYL TRINITRATE; GLYCOPYRRONIUM BROMIDE; INOTROPIC AGENT; ISOFLURANE; METOPROLOL; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; SEVOFLURANE; VASODILATOR AGENT; VERAPAMIL;

ANESTHESIST; CHRONOTROPISM; DISEASE ASSOCIATION; DISEASE COURSE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART MUSCLE ISCHEMIA; HEART RATE; HEMODYNAMICS; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; HYPOTENSION; INOTROPISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SIDE EFFECT; SUDDEN DEATH; SYMPTOMATOLOGY; TACHYCARDIA; TREATMENT INDICATION; ANESTHESIA; CARDIOMEGALY; CLASSIFICATION; HEART MUSCLE; NOMENCLATURE; PATHOLOGY;

ANESTHESIA; CARDIOMEGALY; HUMANS; MYOCARDIUM; TERMINOLOGY;

EID: 33644862338     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200601000-00025     Document Type: Review

References (30)

1. Maron BJ: Hypertrophic cardiomyopathy: A systematic review. JAMA 2002; 287:1308-20
2. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, Ten Cate FJ, Wigle ED: ACC/ESC clinical expert consensus document on hypertrophic cardiomyopathy: A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines (Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy). J Am Coll Cardiol 2003; 42:1687-713
3. Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM: Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA 1999; 281:650-5
4. Klues HG, Schiffers A, Maron BJ: Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995; 26:1699-708
5. Maron BJ: Hypertrophic cardiomyopathy: An important global disease (editorial). Am J Med 2004; 116:63-5
6. Arad M, Maron BJ, Gorham JM, Johnson WH, Saul JP, Perez-Atayde AR, Spirito P, Wright GB, Kanter RJ, Seidman CE, Seidman JG: Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 2005; 352:362-72
7. Ho CY, Sweitzer NK, McDonough B, Maron BJ, Casey SA, Seidman JG, Seidman CE, Solomon SD: Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation 2002; 105:2992-7
8. Maron BJ, Seidman JG, Seidman CE: Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy. J Am Coll Cardiol 2004; 44:2125-32
9. Shirani J, Pick R, Roberts WC, Maron BJ: Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol 2000; 35:36-44
10. Basso C, Thiene G, Corrado D, Buja G, Melacini P, Nava A: Hypertrophic cardiomyopathy and sudden death in the young: Pathologic evidence of myocardial ischemia. Hum Pathol 2000; 31:988-98
11. Klues HG, Roberts WC, Maron BJ: Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy: Significance in producing left ventricular outflow obstruction. Circulation 1991; 84:1188-97
12. Klues HG, Maron BJ, Dollar AL, Roberts WC: Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy. Circulation 1992; 85:1651-60
13. Maron BJ, Niimura H, Casey SA, Soper MK, Wright GB, Seidman JG, Seidman CE: Development of left ventricular hypertrophy in adults with hypertrophic cardiomyopathy caused by myosin-binding protein C gene mutations. J Am Coll Cardiol 2001; 38:315-21
14. Maron BJ: Sudden death in young athletes. N Engl J Med 2003; 349:1064-75
15. Ommen SR, Park SH, Click RL, Freeman WK, Schaff HV, Tajik AJ: Impact of intraoperative transesophageal echocardiography in the surgical management of hypertrophic cardiomyopathy. Am J Cardiol 2002; 90:1022-4
16. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser J, Losi MA Cecchi F, Maron BJ: Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 2003; 348:295-303
17. Wigle ED: Cardiomyopathy: The diagnosis of hypertrophic cardiomyopathy. Heart 2001; 86:709-14
18. Sherrid MV, Gunsburg DZ, Moldenhauer S, Pearle G: Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2000; 36:1344-54
19. Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG: Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003; 349:1027-35
20. Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ: Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 2001; 104:2517-24
21. Sherrid MV, Barac I, McKenna WJ, Elliott PM, Dickie S, Chojnowska L, Casey SA, Maron BJ: Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2005; 45:1251-58
22. Maron BJ, Dearani JA, Ommen SR, Maron MS, Schaff HV, Gersh BJ, Nishimura RA: The case for surgery in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2004; 44:2044-53
23. Faber L, Meissner A, Ziemssen P, Seggewiss H: Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: Long term follow up of the first series of 25 patients. Heart 2000; 83:326-31
24. Maron BJ, Shen W-K, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes III, NAM Spirito P: Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000; 342:365-73
25. Maron BJ, Estes III, NAM Maron MS, Almquist AK, Link MS, Udelson JE: Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. Circulation 2003; 107:2872-5
26. Haering JM, Comunale ME, Parker RA, Lowenstein E, Douglas PS, Krumholz HM, Manning WJ: Cardiac risk of noncardiac surgery in patients with asymmetric septal hypertrophy. ANESTHESIOLOGY 1996; 85:254-9
27. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ: Magnitude of left ventricular hypertrophy predicts the risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000; 342:1778-85
28. Autore C, Conte MR, Piccinnino M, Bernabo P, Bonfiglio G, Bruzzi P, Spirito P: Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol 2002; 40:1864-9
29. Thaman R, Vamava A, Hamid MS, Firoozi S, Sachdev B, Condon M, Gimeno JR, Murphy R, Elliott PM, McKenna WJ: Pregnancy related complications in women with hypertrophic cardiomyopathy. Heart 2003; 89:752-6
30. Autore C, Brauneis S, Apponi F, Commisso C, Pinto G, Fedele F: Epidural anesthesia for cesarean section in patients with hypertrophic cardiomyopathy: A report of three cases. ANESTHESIOLOGY 1999; 90:1205-7